Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-03-2012 | Retinal Disorders

Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography

Authors: Susann Mißner, Ulrich Kellner

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 3/2012

Abstract

Purpose

To compare various screening methods for the early diagnosis of retinal dysfunction in patients with long-term chloroquine (CQ) and hydroxychloroquine (HCQ) treatment.

Methods

Twenty patients with long-term CQ/HCQ treatment underwent ophthalmologic evaluation including visual acuity testing, ophthalmoscopy, fluorescein angiography, color vision tests, visual field and multifocal electroretinography (mfERG).

Results

In 14 patients, retinal dysfunction was indicated in the mfERG (reduced amplitudes and/or delayed implicit times) in the parafoveal area. Towards the periphery, the function was normal or only moderately reduced. Ophthalmoscopy and fluorescein angiography identified pathologic retinal changes in seven of these 14 patients. Six patients had normal mfERG, ophthalmoscopy, and fluorescein angiography. Results of color vision and visual field testing were variable even in patients with morphologic alterations.

Conclusion

The use of mfERG may detect retinal dysfunction in a considerable number of eyes with normal ophthalmocopy and fluorescein angiography. The higher variability of color vision and visual field testing results suggests the use of mfERG as primary screening tool for retinal dysfunction in long-term CQ/HCQ treatment.

Hobbs HE, Sorby A, Freedman A (1959) Retinopathy following chloroquine therapy. Lancet 2:478–480PubMedCrossRef

Shearer RV, Dubois EL (1967) Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy. Am J Ophthalmol 64:245–252PubMed

Bishara SA, Matamoros N (1989) Evaluation of several tests in screening for chloroquine maculopathy. Eye 3:777–782PubMedCrossRef

American College of Rheumatology Ad Hoc Committee on Clinical Guidelines (1996) Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 39:723–727CrossRef

Easterbrook M (1999) Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin 39:49–57PubMedCrossRef

Alacron GS (2002) How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy? Arthritis Rheum 46:561

Semmer AE, Lee MS, Harrison AR, Olsen TW (2008) Hydroxychloroquine retinopathy screening. Br J Ophthalmol 92:1653–1655PubMedCrossRef

Mamor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Opthalmology 109:1377–1382CrossRef

Browning DJ (2002) Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity. Am J Ophthalmol 133:649–656PubMedCrossRef

10.

Warner AE (2001) Early hydroxychloroquine macular toxicity. Arthritis Rheum 4:1959–1961CrossRef

11.

Kellner U, Kraus H, Foerster MH (2000) Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction. Graefes Arch Clin Exp Ophthalmol 238:94–97PubMedCrossRef

12.

So SC, Hedges TR, Schuman JS, Quireza ML (2003) Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography. Ophthalmic Surg Lasers Imaging 34:251–258PubMed

13.

Penrose PJ, Tzekov RT, Sutter EE, Fu AD, Allen AW Jr, Fung WE, Oxford KW (2003) Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina 23:503–512PubMedCrossRef

14.

Maturi RK, Yu M, Weleber RG (2004) Multifocal electroretinographic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol 122:973–981PubMedCrossRef

15.

Moschos MN, Moschos MM, Apostolopoulos M, Mallias JA, Bouros C, Theodossiadis GP (2004) Assessing hydroxychloroquine toxicity by the multifocal ERG. Doc Ophthalmol 108:47–53PubMedCrossRef

16.

Tzekov RT, Serrato A, Marmor MF (2004) ERG findings in patients using hydroxychloroquine. Doc Ophthalmol 108:87–97PubMedCrossRef

17.

Lai TY, Chan WM, Li H, Lai RY, Lam DS (2005) Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol 140:794–807PubMedCrossRef

18.

Lai TY, Ngai JW, Chan WM, Lam DS (2006) Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy. Doc Ophtalmol 112:177–187CrossRef

19.

Kellner U, Renner AB, Tillack H (2006) Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine. Invest Ophthalmol Vis Sci 47:3531–3538PubMedCrossRef

20.

Lyons JS, Severns ML (2009) Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review: Review of mfERG ring ratios in Plaquenil toxicity. Doc Ophthalmol 118:29–36PubMedCrossRef

21.

Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF (2011) Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118:415–422PubMedCrossRef

22.

Kellner U, Kleine-Hartlage P, Foerster MH (1992) Cone dystrophies: clinical and electrophysiological findings. German J Ophthalmol 1:105–109

23.

Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y (2003) Guidelines for basic multifocal electroretinography (mfERG) (for the International Society for Clinical Electrophysiology of Vision). Doc Ophthalmol 106:105–115PubMedCrossRef

24.

Polyak SL (1941) The retina. University of Chicago Press, Chicago

25.

Hood DC, Seiple W, Holopigian K, Greenstein V, Carr RE (1997) A comparison of components of multi-focal and full-field ERGs. Vis Neurosci 14:533–544PubMedCrossRef

26.

Bernstein HN, Ginsberg J (1964) The pathology of chloroquine retinopathy. Arch Ophthalmol 71:238–245PubMedCrossRef

27.

Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL (1978) Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 17:1158–1175PubMed

28.

Wetterholm DH, Winter FC (1964) Histopathology of chloroquine retinal toxicity. Arch Ophthalmol 71:82–87PubMedCrossRef

29.

Shroyer NF, Lewis RA, Lupski JR (2001) Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease? Am J Ophthalmol 131:761–766PubMedCrossRef

30.

Mahon GJ, Anderson HR, Gardiner TA, McFarlane S, Archer DB, Stitt AW (2004) Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy. Curr Eye Res 28:277–284PubMedCrossRef

31.

Bienfang D, Coblyn JS, Liang MH, Corzillius M (2000) Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series. J Rheumatol 27:2703–2706PubMed

32.

Rüther K, Foerster J, Berndt S, Schroeter J (2007) Variabilitat der retinotoxischen Gesamtdosis Chloroquin/Hydroxychloroquin. Ophthalmologe 104:875–887PubMedCrossRef

33.

Rodriguez-Padilla JA, Hedges TR 3rd, Monson B, Srinivasan V, Wojtkowski M, Reichel E, Duker JS, Schuman JS, Fujimoto JG (2007) High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 125:775–780PubMedCrossRef

34.

Kellner S, Weinitz S, Kellner U (2009) Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol 93:1444–1447PubMedCrossRef

Title: Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography
Authors: Susann Mißner
Ulrich Kellner
Publication date: 01-03-2012
Publisher: Springer-Verlag
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 3/2012
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-011-1753-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2012

Comparison of anatomical and visual outcomes of macular hole surgery in patients with high myopia vs. non-high myopia: a case-control study using optical coherence tomography

Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema

Locally produced insulin-like growth factor-1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF-1 for patients with thyroid-associated ophthalmopathy

Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis

Comment Re: Yu AL, Brummeisl W, Schaumberger M, Kampik A, Welge-Lussen U (2010) Vitrectomy does not increase the risk of open-angle glaucoma or ocular hypertension — a 5-year follow-up. Graefes Arch Clin Exp Ophthalmol 248:1407–1414

Proteomic profiling of human retinal pigment epithelium exposed to an advanced glycation-modified substrate